跳至主要内容
临床试验/NCT03143829
NCT03143829已完成不适用

Promoting Cancer Symptom Management in Older Adults

University of Central Florida1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2016年8月11日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
80
试验地点
1
主要终点
Symptom Severity Change Over Time

研究概览

简要总结

The purpose of the project is to estimate the effect size of a technology based intervention for older adults with cancer for nausea and vomiting. Participants will be randomized to either an intervention or a wait control group. Outcomes such as symptom severity, quality of life and resource use will be examined.

详细描述

The goal of this study is to increase the self-management behaviors for chemotherapy induced nausea and vomiting (CINV) and reduce treatment-related negative outcomes in older adults with cancer. CINV is a common reason for unplanned emergency department and/or hospital admissions in older adults with cancer. Early reinforcement of standard education and reframing preconceived beliefs about the potential serious consequences of CINV and the symptoms ability to be successfully managed will increase effective self-management behaviors and improve patient outcomes

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
65 Years 至 —(Older Adult)
性别
All
接受健康志愿者

入选标准

  • Men and women age 65 and older
  • newly diagnosed with any cancer
  • treatment with any chemotherapeutic agent with a moderate to severe emetic potential (on a 3- or 4- week cycle)
  • proficient in English
  • have a telephone.

排除标准

  • Patients with previous diagnosis and treatment for cancer
  • advanced or end stage disease with a palliative intent
  • visually or hearing impaired.

研究组 & 干预措施

Intervention group

Experimental

electronic Symptom Self-Management Training- CINV (eSSET-CINV) is an educational intervention administered once at the start of treatment

干预措施: eSSET-CINV (Other)

Wait Control group

Active Comparator

The Wait control group receives the electronic Symptom Self-Management Training- CINV (eSSET-CINV) at the last study visit. Outcomes will be compared to the Intervention group at the end of the study.

干预措施: eSSET-CINV (Other)

结局指标

主要结局

Symptom Severity Change Over Time

时间窗: assessed at baseline (week 1), week 4,week 7, week 10. differences between groups at week 10 are being reported

Symptom Representation Questionnaire (SRQ)\[20\] , a 24-item self-report measure will be used to identify presence and severity of common treatment-related symptoms (0-10 Likert scale), including nausea and vomiting (N/V). This measure asks respondents to think about their symptoms over the past week. Higher values indicate a worse outcome

Self-management Behaviors Over Time

时间窗: data was assessed at weeks 4,7, 10, the mean number of behaviors (behaviors) combined at each time point is reported

An investigator-developed Symptom Management Checklist (SMC) will measure CINV self-management prevention behaviors. Participants will complete this daily at home between chemotherapy cycles. Higher numbers indicate more frequent management.

Health-related Quality of Life Change Over Time

时间窗: assessed at baseline (week 1), week 4, week 7, week 10. the difference between groups at week 10 is being reported

The EORTC-30\[21\] will measure QOL at each treatment cycle. 0-10 scale, higher scores mean better outcome

Resource Use Over Time

时间窗: assessed at weeks 4,7,10. the total number of admissions was summed across all time points and participants

Any unplanned Emergency Department or hospital admission will be recorded via participant report. Higher number indicate higher resource use.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验